
ScitoVation, a biotech firm, leverages science and technology to enhance human health through safer pharmaceuticals and food ingredients.
scitovation.comCrawled Oct 14, 2026
The page discusses physiological relevance and exposure route as factors in developing in vitro inhalation toxicity assays. It compares organotypic models for repeat exposures with cell-line models for high-throughput acute testing.
Posted by Leslie Recio, PhD DABT Like all the biological sciences, the genomic revolution has significantly impacted the science and practice of
The page recounts a webinar presented by Scott Slattery on in vitro inhalation point-of-contact toxicity testing with vapors and the author's work on the project.
The company featured Chief Scientific Officer Leslie Recio, PhD, DABT, in a May 10 webinar.
Larry Bowen will be joining ScitoVation as an In Vitro Lung Inhalation Scientist to assist in ongoing research in the in vitro-based safety assessment
ScitoVation's team works to assess the safety of chemicals and products through toxicology research.
The company aims to improve human health by helping clients develop pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals, and consumer products.
ScitoVation is a contract research organization that helps clients assess chemical compound safety. It works with pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals, and consumer products.
The page lists ScitoVation's Durham address, mailing address, phone number, and customer service email.
ScitoVation provides computational toxicology for chemical, pharmaceutical, consumer-product, and regulatory teams, helping them reach human-relevant conclusions. The page also promotes the ScitoSim platform and a webinar on generative learning of single-cell gene expression.
ScitoVation's Website Privacy Policy explains how the company collects, uses, discloses, and protects personal information when people visit its website, submit forms, communicate with the company, or register for a webinar.